Parents Are Very Open to Ketamine Therapy for Kids, Study Finds
“As parents maintain decision-making capacity of their child’s medical care, parental consent is a key factor in the adoption of new treatments for adolescents,” study authors explain.
Author: Emily Jarvie
Are We Being Exposed to Psychedelics More Than Ever Before? Survey Says…It’s Complicated
A study of American newspaper mentions of psychedelics doesn’t stack up to what leaders in the industry are observing in the media landscape at large.
Psychedelic Business Spotlight: October 29
This week in psychedelic business news: MindMed’s MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.
FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain
“This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding,” says Cybin’s chief clinical officer.
Psychedelic Patents Should Be Limited, Harvard Law Experts Say
“If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted,” warn researchers.
Psychedelic Business Spotlight: October 22
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company prepares for the Nasdaq.
Fourth Massachusetts City Decriminalizes Psychedelic Plants
The resolution, however, does not authorize the commercial sale of entheogenic plants and fungi, nor cultivation for large-scale distribution.
UK Prime Minister Boris Johnson to Consider Legalizing Psilocybin
The leader of the Conservative Party in the United Kingdom tells a Member of Parliament “we will consider the Advisory Council on the Misuse of Drugs’ recent advice on reducing barriers to research with controlled drugs.”
Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years
A Johns Hopkins Medicine professor says “it was only a matter of time,” while lead researcher calls the historic grant “monumental” for the psychedelics movement.
Comedy Superstar Russell Peters Invites the World to Watch His First Psychedelic Trip
The comedian and Netflix star will ingest psilocybin truffles from Red Light Holland, a company for which he serves as chief creative officer.
End of content
End of content